Post-Inflammatory Hyper-and Hypopigmentation: Differential Diagnosis & Practical Treatment Approaches
During ODAC 2025, Dr. Pooja Sodha — Associate Professor of Dermatology and Director of Laser and Cosmetic Dermatology at GWU School of Medicine and Health Sciences — presented a clinically focused review of the differential diagnosis and stepwise treatment strategies for post-inflammatory hyper‑ and hypopigmentation.
Post-Inflammatory Hyperpigmentation
Post-inflammatory hyperpigmentation …
During ODAC 2025, Dr. Pooja Sodha — Associate Professor of Dermatology and Director of Laser and Cosmetic Dermatology at GWU School of Medicine and Health Sciences — presented a clinically focused review of the differential diagnosis and stepwise treatment strategies for post-inflammatory hyper‑ and hypopigmentation.
Post-Inflammatory Hyperpigmentation
Post-inflammatory hyperpigmentation … 
Concerns over nail salon safety typically focus on the dangers of UV lights or risks of a salon-acquired infection. A brief communication published in the October Journal of Drugs in Dermatology expands the thinking on the dermatologic hazards of nail products, both those used in the salon and at home. From unexpected nail changes to allergic reactions, the authors state that dermatologists should … 
There are four types of Kaposi Sarcoma. The viral strain associated with classic AIDS-associated Kaposi Sarcoma is:
A. HHV-8
B. HHV-6
C. HHV-5
D. HHV-4
E. HHV-3
To find out the correct answer and read the explanation, click here.
Brought to you by our brand partner
*Brand partners had no involvement in the content of the questions or answers.
& … 
Treating alopecia in children requires some unique considerations. Next Steps in Derm, in partnership with the ODAC Dermatology Conference interviewed Dr. Michelle Oboite, assistant professor of clinical dermatology at Penn Medicine and an attending physician with the Children's Hospital of Philadelphia. Watch as Dr. Oboite shares the unique types of hair loss to consider in children. Learn strate … 
JAK inhibitors have rapidly moved from investigational agents to important therapeutic options in pediatric dermatology, offering powerful control for conditions such as atopic dermatitis and alopecia areata. Yet their rising use brings practical clinical questions about patient selection, dosing, monitoring, and long‑term safety—questions that are especially urgent when treating children, who …